Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.37
-$0.05-1.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.26% | -4.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.94% | 6.41% | |||
| Operating Income | 15.94% | -6.41% | |||
| Income Before Tax | -85.98% | -8.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -85.98% | -8.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -85.98% | -8.42% | |||
| EBIT | 15.94% | -6.41% | |||
| EBITDA | 15.97% | -6.36% | |||
| EPS Basic | -85.91% | -8.03% | |||
| Normalized Basic EPS | 15.92% | -8.04% | |||
| EPS Diluted | -85.91% | -8.03% | |||
| Normalized Diluted EPS | 15.92% | -8.04% | |||
| Average Basic Shares Outstanding | 0.04% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.04% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||